Delivery Order SPE2DR25D2005-SPE2DR26FE7V7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on November 7, 2025, with a ceiling value of $1,212.74 and an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lantus SoloStar insulin (100 unit/mL, 3mL formulation) with a ceiling value of $1,022.80. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award to the vendor. The contract is to be completed by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $4,398.30. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $2,435.84 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on September 23, 2025, with completion expected by September 24, 2025. This firm fixed-price contract represents a single delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,775.19 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin products. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, valued at $1,113.75. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.54 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, a 3mL pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, executed on November 18, 2025, with an ultimate completion date of November 19, 2025. Performance will be executed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7V7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, with a ceiling value of $1,967.64 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical and medical supply needs through open competition with the Defense Logistics Agency and its Medical Supply Chain. This delivery order for diabetes medication insulin continues AmerisourceBergen's established role in supporting the Defense Health Agency and other government healthcare systems through the DLA's flexible contract vehicles for pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/30/25 |